Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.
Ehrlich A, Ioannidis K, Nasar M, Abu Alkian I, Daskal Y, Atari N, Kliker L, Rainy N, Hofree M, Shafran Tikva S, Houri I, Cicero A, Pavanello C, Sirtori CR, Cohen JB, Chirinos JA, Deutsch L, Cohen M, Gottlieb A, Bar-Chaim A, Shibolet O, Mandelboim M, Maayan SL, Nahmias Y. Ehrlich A, et al. Among authors: mandelboim m. Elife. 2023 Jan 27;12:e79946. doi: 10.7554/eLife.79946. Elife. 2023. PMID: 36705566 Free PMC article. Clinical Trial.
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Lustig Y, Zuckerman N, Nemet I, Atari N, Kliker L, Regev-Yochay G, Sapir E, Mor O, Alroy-Preis S, Mendelson E, Mandelboim M. Lustig Y, et al. Among authors: mandelboim m. Euro Surveill. 2021 Jul;26(26):2100557. doi: 10.2807/1560-7917.ES.2021.26.26.2100557. Euro Surveill. 2021. PMID: 34212838 Free PMC article.
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G. Bergwerk M, et al. Among authors: mandelboim m. N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28. N Engl J Med. 2021. PMID: 34320281 Free PMC article.
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R.
Mor O, Mandelboim M, Fleishon S, Bucris E, Bar-Ilan D, Linial M, Nemet I, Kliker L, Lustig Y, Israel National Consortium For Sars-CoV-Sequencing, Mendelson ES, Zuckerman NS. Mor O, et al. Among authors: mandelboim m. Vaccines (Basel). 2021 Aug 23;9(8):937. doi: 10.3390/vaccines9080937. Vaccines (Basel). 2021. PMID: 34452062 Free PMC article.
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Zuckerman N, Nemet I, Kliker L, Atari N, Lustig Y, Bucris E, Bar Ilan D, Geva M, Sorek-Abramovich R, Weiner C, Rainy N, Bar-Chaim A, Benveniste-Levkovitz P, Abu Hamed R, Regev-Yochay G, Hevkin O, Mor O, Alroy-Preis S, Mendelson E, Mandelboim M. Zuckerman N, et al. Among authors: mandelboim m. Euro Surveill. 2021 Nov;26(45):2100974. doi: 10.2807/1560-7917.ES.2021.26.45.2100974. Euro Surveill. 2021. PMID: 34763751 Free PMC article.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
Gilboa M, Mandelboim M, Indenbaum V, Lustig Y, Cohen C, Rahav G, Asraf K, Amit S, Jaber H, Nemet I, Kliker L, Bar-Haim E, Mendelson E, Doolman R, Rubin C, Regev-Yochay G, Kreiss Y. Gilboa M, et al. Among authors: mandelboim m. J Infect Dis. 2022 Mar 2;225(5):785-792. doi: 10.1093/infdis/jiab584. J Infect Dis. 2022. PMID: 34850049
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Katz MA, Harlev EB, Chazan B, Chowers M, Greenberg D, Peretz A, Tshori S, Levy J, Yacobi M, Hirsch A, Amichay D, Weinberger R, Dor AB, Taraday EK, Reznik D, Chayat CB, Sagas D, Zvi HB, Berdinstein R, Rashid G, Avni YS, Mandelboim M, Zuckerman N, Rainy N, Akriv A, Dagan N, Kepten E, Barda N, Balicer RD. Katz MA, et al. Among authors: mandelboim m. Vaccine. 2022 Jan 24;40(3):512-520. doi: 10.1016/j.vaccine.2021.11.092. Epub 2021 Dec 10. Vaccine. 2022. PMID: 34903372 Free PMC article.
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, Kreiss Y, Alroy-Preis S, Regev-Yochay G, Mendelson E, Mandelboim M. Nemet I, et al. Among authors: mandelboim m. N Engl J Med. 2022 Feb 3;386(5):492-494. doi: 10.1056/NEJMc2119358. Epub 2021 Dec 29. N Engl J Med. 2022. PMID: 34965337 Free PMC article. No abstract available.
Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
Kriger O, Gefen-Halevi S, Leshem E, Smollan G, Belausov N, Egbarye A, Khashab R, Odeh M, Saffia A, Barak Y, Hussein OA, Hamias R, Aharon Y, Alfandari J, Nemet I, Kliker L, Sherbany H, Mandelboim M, Amit S. Kriger O, et al. Among authors: mandelboim m. Int J Infect Dis. 2022 Mar;116:226-229. doi: 10.1016/j.ijid.2022.01.018. Epub 2022 Jan 14. Int J Infect Dis. 2022. PMID: 35038602 Free PMC article.
188 results